PAHC Phibro Animal Health Corporation

PAHC Phibro Animal Health Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 2 scans as of 2026-10-16 2 neutral converging

POC $35.54 · VWAP $41.48 · -6.4% vs 12m avg buyer

basing vol: compressedgaps: overnight-shiftchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 related campaign

Watchlists @livestock-disease

PAHC Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist PAHC belongs to, members best 30-day change first — PAHC highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings PAHC reports in 18 days Nov 4

Last report Aug 26

Reported EPS $0.85 versus analyst consensus of $0.73 (+17.1%).

full note →

Against street estimates

How PAHC's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 26 · projection Oct 16

Result
Aug 26 0.730.85+17.1%Beat
May 6 0.710.76+6.5%Beat
Feb 4 0.670.87+29.9%Beat
Nov 5 '25 0.600.73+21.1%Beat
Aug 27 '25 0.520.57+9.3%Beat
May 7 '25 0.520.63+21.1%Beat
Feb 5 '25 0.450.54 GAAP ≠ +19.2%Beat
Nov 6 '24 0.250.35 GAAP ≠ +41.4%Beat

Recent news

Headlines about PAHC from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 2 days ago · Oct 15

Types
Aug 26 Catalyst PAHC earnings